Schonfeld Strategic Advisors LLC - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 81 filers reported holding EIDOS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$384,000
-69.3%
7,600
-65.1%
0.01%
-76.7%
Q4 2019$1,251,000
-64.7%
21,800
-77.9%
0.03%
-71.2%
Q3 2019$3,547,000
+68.1%
98,600
+45.2%
0.10%
+38.7%
Q2 2019$2,110,000
-51.4%
67,901
-63.4%
0.08%
-50.3%
Q1 2019$4,345,000
+4245.0%
185,300
+1753.0%
0.15%
+3675.0%
Q3 2018$100,00010,0000.00%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$56,777,00018.14%
Board of Trustees of The Leland Stanford Junior University 265,670$13,425,0005.17%
Opaleye Management Inc. 315,550$15,945,0003.12%
RA Capital Management 2,163,271$109,310,0002.00%
Cormorant Asset Management, LP 993,185$50,186,0001.93%
Parkman Healthcare Partners LLC 41,091$2,076,0000.55%
Perceptive Advisors 686,922$34,710,0000.51%
Redmile Group, LLC 466,205$23,557,0000.43%
Eventide Asset Management 317,417$16,039,0000.31%
Ikarian Capital, LLC 63,011$3,184,0000.23%
View complete list of EIDOS THERAPEUTICS INC shareholders